Rikako Tabata

425 total citations
35 papers, 189 citations indexed

About

Rikako Tabata is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Rikako Tabata has authored 35 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 10 papers in Pathology and Forensic Medicine and 9 papers in Molecular Biology. Recurrent topics in Rikako Tabata's work include Multiple Myeloma Research and Treatments (17 papers), Lymphoma Diagnosis and Treatment (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Rikako Tabata is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Lymphoma Diagnosis and Treatment (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Rikako Tabata collaborates with scholars based in Japan. Rikako Tabata's co-authors include Kentaro Narita, Masami Takeuchi, Kosei Matsue, Junichiro Yuda, Yosuke Minami, Daisuke Miura, Toshiki Terao, Daisuke Ikeda, Youichi Machida and Ukihide Tateishi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Rikako Tabata

31 papers receiving 185 citations

Peers

Rikako Tabata

HEMAT

ONCOL

IMMUN

Hira Shaikh United States

Anne Lok France

Anna Sicuranza Italy

Olga Samoylova Russia

Kenji Nara Japan

Ilaria Scortechini Italy

Chantiya Chanswangphuwana Thailand

Paola Minetto Italy

Alessandra Algarotti Italy

Fabio Guolo Italy

Hira Shaikh United States

Rikako Tabata

71 ×0.8

HEMAT

101 ×1.2

ONCOL

58 ×1.0

31 ×0.6

IMMUN

30 ×0.8

Citations per year, relative to Rikako Tabata Rikako Tabata (= 1×) peers Hira Shaikh

Countries citing papers authored by Rikako Tabata

Since Specialization

Citations

This map shows the geographic impact of Rikako Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikako Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikako Tabata more than expected).

Fields of papers citing papers by Rikako Tabata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikako Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikako Tabata. The network helps show where Rikako Tabata may publish in the future.

Co-authorship network of co-authors of Rikako Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Rikako Tabata. A scholar is included among the top collaborators of Rikako Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikako Tabata. Rikako Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ikeda, Daisuke, Hajime Sakuma, Rikako Tabata, et al.. (2024). Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma. Blood. 145(5). 526–532. 5 indexed citations

Ikeda, Daisuke, Rikako Tabata, Kentaro Narita, et al.. (2024). Prognostic relevance of tumor-infiltrating CD4<sup>+</sup> cells and total metabolic tumor volume-based risk stratification in diffuse large B-cell lymphoma. Haematologica. 109(9). 2822–2832. 3 indexed citations

Narita, Kentaro, Youichi Machida, Daisuke Ikeda, et al.. (2024). Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath. Blood. 144(Supplement 1). 491–491. 2 indexed citations

Ikeda, Daisuke, et al.. (2024). Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies. Cancer Chemotherapy and Pharmacology. 94(3). 397–406. 1 indexed citations

Tabata, Rikako & Kosei Matsue. (2024). ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever. Blood. 144(13). 1460–1460.

Sakuma, Hajime, et al.. (2024). Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma. Blood. 144(Supplement 1). 4682–4682.

Ikeda, Daisuke, Toshiki Terao, Rikako Tabata, et al.. (2023). Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood Advances. 8(1). 37–46. 2 indexed citations

Narita, Kentaro, Daisuke Ikeda, Rikako Tabata, et al.. (2023). Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice. Japanese Journal of Clinical Oncology. 53(10). 991–995. 2 indexed citations

Terao, Toshiki, Kentaro Narita, Daisuke Ikeda, et al.. (2023). Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis. American Journal of Clinical Pathology. 160(2). 157–163. 2 indexed citations

10.

Honma, Koichi, Daisuke Ikeda, Rikako Tabata, et al.. (2023). Concordance between HokUS-10 Scoring and Transjugular Liver Biopsy for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(10). 639.e1–639.e4. 1 indexed citations

11.

Ikeda, Daisuke, Toshiki Terao, Rikako Tabata, et al.. (2023). A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma. Blood. 142(Supplement 1). 1972–1972. 1 indexed citations

12.

Narita, Kentaro, So Nakaji, Rikako Tabata, et al.. (2022). Antibody response to COVID-19 vaccination in patients with lymphoma. International Journal of Hematology. 115(5). 728–736. 11 indexed citations

13.

Terao, Toshiki, Takeshi Yamashita, Daisuke Ikeda, et al.. (2022). Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma. International Journal of Hematology. 115(5). 737–747. 6 indexed citations

14.

Terao, Toshiki, Daisuke Ikeda, Rikako Tabata, et al.. (2022). Depletion of CD38‐positive regulatory T cells by anti‐CD38 monoclonal antibodies induces a durable response to SARS‐CoV‐2 vaccination in patients with plasma cell dyscrasia. British Journal of Haematology. 197(4). 417–421. 8 indexed citations

15.

Terao, Toshiki, Rikako Tabata, Daisuke Miura, et al.. (2022). Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases. International Journal of Hematology. 116(4). 579–585. 3 indexed citations

16.

Terao, Toshiki, Youichi Machida, Kentaro Narita, et al.. (2021). Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma. European Radiology. 31(8). 6136–6144. 16 indexed citations

17.

Terao, Toshiki, Ken‐ichi Matsuoka, Kentaro Narita, et al.. (2021). Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide. Frontiers in Oncology. 11. 666774–666774. 4 indexed citations

18.

Narita, Kentaro, Daisuke Miura, Toshiki Terao, et al.. (2021). Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria. Scientific Reports. 11(1). 14956–14956. 2 indexed citations

19.

Tabata, Rikako, Toshiki Terao, Daisuke Miura, et al.. (2021). Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. British Journal of Haematology. 193(4). e33–e36. 14 indexed citations

20.

Miura, Daisuke, Kentaro Narita, Rikako Tabata, et al.. (2019). Clinical and Prognostic Impact of (11;14)(q13;q32) Translocation on Patients with Multiple Myeloma. Blood. 134(Supplement_1). 5507–5507. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact